Antidotal therapy: pharmacokinetic aspects.
D000284:Administration, Oral; D000931:Antidotes / Q000627:therapeutic use*; D003676:Deferoxamine / Q000627:therapeutic use; D004112:Dimercaprol / Q000627:therapeutic use; D006358:Hot Temperature; D006801:Humans; D007273:Injections, Intramuscular; D007700:Kinetics; D009270:Naloxone / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D005082:Physical Exertion; D011041:Poisoning / Q000188:drug therapy*; D011220:Pralidoxime Compounds / Q000627:therapeutic use; D013831:Thiamine / Q000494:pharmacology
D000931:Antidotes; D011220:Pralidoxime Compounds; D004112:Dimercaprol; D009270:Naloxone; D010396:Penicillamine; D003676:Deferoxamine; C028797:pralidoxime; D013831:Thiamine